on Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health to Present at Emerging Growth Conference
Jaguar Health, Inc. (NASDAQ:JAGX) has announced that CEO Lisa Conte will present at the Emerging Growth Conference on February 18, 2025. The virtual event requires online registration for participation, and a replay will be available on EmergingGrowth.com and YouTube.
Jaguar Health focuses on developing proprietary prescription medicines derived from rainforest plants, addressing gastrointestinal issues like chronic diarrhea. Their subsidiary, Napo Pharmaceuticals, developed Mytesi®, an FDA-approved treatment for noninfectious diarrhea in HIV/AIDS patients. Napo Therapeutics, formed in Italy, aims to expand crofelemer's access in Europe.
The announcement includes forward-looking statements about the presentation. Jaguar Health cautions that these statements are predictions, subject to risks and uncertainties. The company does not intend to update statements unless legally required.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Jaguar Health, Inc. news